Updated hourlyHourly refreshThu, Sep 3, 2026
Press Release Database
Recent press releases, indexed by topic.
Finance · SaaS
LONDON, September 02, 2026--HPE (NYSE: HPE) and Tottenham Hotspur Football Club (Spurs), today announced an expansion of their long-standing partnership. As the Club's Official Hybrid Cloud and IT Enterprise Networking Partner, HPE will modernize the technology environment that powers Spurs’ Stadium. From ticketless entry and cashless payments to mobile applications, digital wayfinding, and high-density connectivity, the transformation will support every digital interaction across the supporter
Sep 2 · 06:00·mlpr-businesswire
Finance
Civinity, a building maintenance, engineering and technology solutions group, together with Sail Invest, a company controlled by Domas Dargis, has completed the acquisition of the Vilnius-based building management company Admeo. Through their jointly controlled company SPV 31, the buyers acquired 100% of the shares in Admeo.
Sep 2 · 05:58·GlobeNewswire
Finance
Jyske Bank A/S (Jyske Bank) has entered into a binding agreement with the shareholders of FP Kapital A/S on the acquisition of 100% of the shares of FP Kapital A/S (Formuepleje).
Sep 2 · 05:58·GlobeNewswire
Finance
- Cellebrite Federal Solutions, Inc. (CFSI) obtiene el Estándar Avanzado de Ciberseguridad del Departamento de Guerra de EE.UU., reforzando el compromiso con la seguridad de las operaciones federales TYSONS CORNER, Va., 2 de septiembre de 2026 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), un...
Sep 2 · 05:22·PR Newswire
Finance · Healthcare
MARSEILLE, France, September 02, 2026--Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), a clinical-stage biotechnology company developing immunotherapies for cancer patients, today announced that members of its executive team will participate in a fireside chat and one-on-one investor meetings at the following conference:
Sep 2 · 05:00·mlpr-businesswire
Finance
TYSONS CORNER, Virginia, 2. September 2026 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), ein weltweit führender Anbieter von KI-gestützten digitalen Ermittlungs- und Aufklärungslösungen für den öffentlichen und privaten Sektor, gab heute bekannt, dass seine Tochtergesellschaft Cellebrite...
Sep 2 · 04:49·PR Newswire
Finance
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ:AARD) securities. If you suffered a loss on your Aardvark Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Aardvark Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of a class ..
Sep 2 · 04:30·PR-Inside
Finance
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) securities. If you suffered a loss on your ARS Pharmaceuticals investment and would like to explore a potential recovery under the federal securities laws, Learn about ARS Pharmaceuticals Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ARS Pharmaceuticals, ..
Sep 2 · 04:30·PR-Inside
Finance
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Aardvark Therapeutics, Inc. (NASDAQ:AARD) securities. If you suffered a loss on your Aardvark Therapeutics, Inc. investment and would like to explore a potential recovery under the federal securities laws, Learn about Aardvark Therapeutics, Inc. Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: This lawsuit is on behalf of a class ..
Sep 2 · 04:10·PR-Inside
Finance
(PR-inside.com) NEW YORK, NY / ACCESS Newswire / September 2, 2026 / Levi & Korsinsky, LLP announces that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Wise Group plc (NASDAQ:WSE) securities. If you suffered a loss on your Wise Group plc investment and would like to explore a potential recovery under the federal securities laws, Learn about Wise Group plc Class Action or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call (212)363-7500 to speak to our team of experienced shareholder advocates. THE LAWSUIT: A class action securities lawsuit was filed against ..
Sep 2 · 04:05·PR-Inside
Finance
NEW YORK, Sept. 1, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) between March 9, 2026 and June 24, 2026, inclusive (the "Class Period"), of the important October 5, 2026 lead...
Sep 2 · 03:58·PR Newswire
Finance
NEW YORK, Sept. 1, 2026 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Aardvark Therapeutics, Inc. (NASDAQ: AARD): (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement")...
Sep 2 · 03:47·PR Newswire